Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
47.58
Oct 20 • 3:59 PM ET Dollar change+1.53 Percentage change(3.32%)
Aftermarket Close
47.58
Aftermarket • 5:00 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
1.43B
Enterprise Value
2.22B
Income
56.50M
Sales
1.37B
Book/sh
34.73
Cash/sh
1.25
Employees
3900
IPO
Jul 23, 1987
P/E
25.73
Forward P/E
9.95
PEG
1.80
P/S
1.04
P/B
1.37
P/C
38.18
P/FCF
10.60
EV/EBITDA
10.76
EV/Sales
1.62
Quick Ratio
0.69
Current Ratio
1.48
Debt/Eq
0.80
LT Debt/Eq
0.63
Option/Short
Yes / Yes
EPS (ttm)
1.85
EPS next Y
4.78
EPS next Q
1.00
EPS this Y
-1.18%
EPS next Y
5.42%
EPS next 5Y
5.53%
EPS past 3/5Y
- 36.14%
Sales past 3/5Y
10.08% 9.82%
EPS Y/Y TTM
-48.06%
Sales Y/Y TTM
3.86%
EPS Q/Q
11.05%
Sales Q/Q
0.21%
Insider Own
0.39%
Insider Trans
0.00%
Inst Own
114.14%
Inst Trans
-0.92%
ROA
2.44%
ROE
5.53%
ROIC
3.33%
Gross Margin
53.68%
Oper. Margin
10.95%
Profit Margin
4.11%
SMA20
3.78%
SMA50
0.05%
SMA200
15.40%
Trades
Shs Outstand
29.99M
Shs Float
29.84M
52W High
53.66 -11.33%
52W Low
31.44 51.34%
Volatility
4.22% 3.53%
ATR (14)
1.69
RSI (14)
56.24
Beta
0.90
Rel Volume
1.07
Avg Volume
412.92K
Volume
440,171
Perf Week
4.46%
Perf Month
6.47%
Perf Quarter
13.29%
Perf Half Y
24.07%
Perf YTD
17.19%
Perf Year
-0.42%
Perf 3Y
-48.55%
Perf 5Y
-67.20%
Perf 10Y
18.56%
Prev Close
46.05
Price
47.58
Change %
3.32%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kelderman KimDirectorSep 08 '26Option Exercise0.005000500Sep 10 03:13 PM
Bronson David M.DirectorJun 02 '26Option Exercise0.00668017,909Jun 03 04:22 PM
Council LaVerne HDirectorJun 02 '26Option Exercise0.0066804,716Jun 03 04:18 PM
Farkas CharlesDirectorJun 02 '26Option Exercise0.00668015,527Jun 03 04:12 PM
Kaye MarkDirectorJun 02 '26Option Exercise0.006680820Jun 03 04:10 PM
Schwarzentraub Barbara JDirectorJun 02 '26Option Exercise0.0066805,012Jun 03 04:07 PM
Lalomia BrentExecutive VP RA, QAMar 06 '26Option Exercise0.00750941Mar 10 02:40 PM
Kaye MarkDirectorFeb 24 '26Option Exercise0.001520152Feb 26 09:23 AM
Glaze RichardChief Information OfficerNov 21 '25Sale41.2125710,5910Nov 24 01:18 PM
Glaze RichardChief Information OfficerNov 20 '25Option Exercise0.003750375Nov 21 03:39 PM
Glaze RichardOfficerNov 21 '25Proposed Sale41.2125710,591Nov 21 09:40 AM
Garner Todd WExecutive Vice President & CFONov 06 '25Sale43.003,500150,5001,836Nov 07 04:06 PM
Garner Todd WOfficerNov 06 '25Proposed Sale43.003,500150,500Nov 06 09:42 AM
Foust Hollie KGeneral Counsel & Corp SecNov 04 '25Option Exercise0.004,00004,000Nov 05 04:03 PM
Garner Todd WExecutive Vice President & CFOOct 31 '25Option Exercise0.007,50007,500Nov 03 04:47 PM
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.
PresidentMr. Patrick J. Beyer
Executive VPMs. Hollie K. Foust
Executive Vice President of Strategy & Corporate DevelopmentMr. Peter K. Shagory
AdvisorMr. Todd W. Garner CPA
Executive VP of Regulatory AffairsMr. Brent Lalomia